Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Biomedicines|January 8, 2025
Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic DiseasesIgor Aurer, Ozren Jakšić, Sandra Bašić-Kinda, et al.The Oncologist|June 17, 2025
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion reviewIgor Aurer, Paul Moss, Michel Goldman, et al.Hemasphere|October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphomaMats Jerkeman, Igor Aurer, Elias Campo, et al.Clinical Lymphoma, Myeloma & Leukemia|October 11, 2018
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative NeoplasmsIvana Horvat, Ana Boban, Renata Zadro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup TrialPatrice Carde, Matthias Karrasch, Catherine Fortpied, et al.Biomedicines|November 26, 2022
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A ReviewVibor Milunović, Ida Hude, Goran Rinčić, et al.Biomedicines|November 26, 2022
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHemZrinka Sertić, Marko Lucijanić, Sandra Bašić-Kinda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphomaAndreas Josting, Horst Müller, Peter Borchmann, et al.Hemasphere|June 25, 2026
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-upDennis A Eichenauer, Marc André, Peter Borchmann, et al.Cancers|July 29, 2025
Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia-A KroHem StudyInga Mandac Smoljanović, Igor Aurer, Nikola Bulj, et al.Pageof 7